Often described as the most important development in data privacy regulation, the General Data Protection Regulation (GDPR) is intended to strengthen data security for individuals. Join Aly Talen and Nico Busch for a 30-min. webinar to better understand how the GDPR will impact clinical trials.
The FDA this week published a finalized guidance document for companies developing new buprenorphine depot products for the treatment of opioid use disorder.
What I appreciate the most about genae is the consistent level of quality they produce. Our medical device study team is knowledgeable, capable and experienced; flexible with our changing needs, and very responsive to our concerns.
— Sara Vidmar, Vice President Clinical & Regulatory Affairs, Mitralign Inc., USA
Want to hear more about our services or how we can support your project? Feel free to contact us with any questions you may have.Contact us